解放军医学院学报2017,Vol.38Issue(6):516-518,3.DOI:10.3969/j.issn.2095-5227.2017.06.007
小细胞和非小细胞化疗方案对肺大细胞神经内分泌癌的疗效比较
Effectiveness of small cell lung cancer vs non-small cell lung cancer chemotherapy regimens on pulmonary large cell neuroendocrine carcinoma
左震华 1李小勇 2蔡少华1
作者信息
- 1. 解放军总医院 国宾一科,北京 100853
- 2. 河北省遵化市人民医院 呼吸科,河北遵化 064200
- 折叠
摘要
Abstract
Objective The treatment of large cell neuroendocrine carcinoma (LCNEC) is inconclusive, We evaluated whether advanced LCNEC should be treated similarly to small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC). Methods Total of 23 patients were diagnosed as advanced LCNEC retrospectively examined and divided into SCLC regimen group (n=13) and NSCLC regimen group (n=10) according to first-line chemotherapeutic regimens. Results Most patients were male with a median age of 62.5 years. The survival rates in SCLC regimen group and NSCLC regimen group were 8.2% and 7.1% (P=0.27), respectively. Conclusion Regarding chemotherapy for advanced LCNEC, SCLC regimen is superior to NSCLC.关键词
大细胞神经内分泌癌/肺癌/化疗Key words
large-cell neouroendocrine carcinoma/lung cancer/chemotherapy分类
医药卫生引用本文复制引用
左震华,李小勇,蔡少华..小细胞和非小细胞化疗方案对肺大细胞神经内分泌癌的疗效比较[J].解放军医学院学报,2017,38(6):516-518,3.